Parties d'ouvrages collectifs (1)
  1. 1. Spruyt, D., Gillet, C., & Rasschaert, J. (2018). Bone and bone marrow; interactions. In Encyclopedia of Endocrine Diseases (pp. 31-39). Elsevier. doi:10.1016/B978-0-12-801238-3.66157-3
    2.   Articles dans des revues avec comité de lecture (107)
  2. 1. Sun, D., Chasseur, C., Mathieu, F., Lechanteur, J., Van Antwerpen, P., Rasschaert, J., Fontaine, V., & Delporte, C. (2023). Untargeted Metabolomics Approach Correlated Enniatin B Mycotoxin Presence in Cereals with Kashin-Beck Disease Endemic Regions of China. Toxins, 15(9). doi:10.3390/toxins15090533
  3. 2. Sidiras, P., Lechanteur, J., Imbault, V., Sokolova, T., Durez, P., Gangji, V., Communi, D., & Rasschaert, J. (2022). Human carbamylome description identifies carbamylated α2-macroglobulin and hemopexin as two novel autoantigens in early rheumatoid arthritis. Rheumatology (Online), 61(7), 2826-2834. doi:10.1093/rheumatology/keab838
  4. 3. Sidiras, P., Lechanteur, J., Imbault, V., Sokolova, T., Durez, P., Gangji, V., Communi, D., & Rasschaert, J. (2021). Human carbamylome description identifies carbamylated α2-macroglobulin and hemopexin as two novel autoantigens in early rheumatoid arthritis. Rheumatology. doi:10.1093/rheumatology/keab838
  5. 4. La, C., Lê, P. Q., Ferster, A., Spruyt, D., Goffin, L., Lauwerys, B. B., Durez, P., Boulanger, C., Sokolova, T., Rasschaert, J., & Badot, V. (2021). Serum calprotectin (S100A8/A9): A promising biomarker in diagnosis and follow-up in different subgroups of juvenile idiopathic arthritis. RMD Open, 7(2), 001646. doi:10.1136/rmdopen-2021-001646
  6. 5. Hernigou, J., Vertongen, P., Rasschaert, J., & Hernigou, P. (2021). Role of scaffolds, subchondral, intra-articular injections of fresh autologous bone marrow concentrate regenerative cells in treating human knee cartilage lesions: Different approaches and different results. International journal of molecular sciences, 22(8), 3844. doi:10.3390/ijms22083844
  7. 6. Sidiras, P., Spruyt, D., Gangji, V., Imbault, V., Sokolova, T., Durez, P., Communi, D., Rasschaert, J., & Badot, V. (2020). Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases. Scandinavian journal of rheumatology, 1-6. doi:10.1080/03009742.2020.1798500
  8. 7. Sidiras, P., Spruyt, D., Gangji, V., Imbault, V., Sokolova, T., Durez, P., Communi, D., Rasschaert, J., & Badot, V. (2020). Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases. Scandinavian journal of rheumatology. doi:10.1080/03009742.2020.1798500
  9. 8. Dalla Valle, A., Vertongen, P., Spruyt, D., Lechanteur, J., Suain, V., Gaspard, N., Brion, J. P., Gangji, V., & Rasschaert, J. (2019). Induction of Stearoyl-CoA 9-Desaturase 1 Protects Human Mesenchymal Stromal Cells Against Palmitic Acid-Induced Lipotoxicity and Inflammation. Frontiers in endocrinology, 10, 726. doi:10.3389/fendo.2019.00726
  10. 9. Hernigou, J., Vertongen, P., Chahidi, E., Kyriakidis, T., Dehoux, J. P., Crutzen, M., Boutry, S., Larbanoix, L., Houben, S., Gaspard, N., Koulalis, D., & Rasschaert, J. (2018). Effects of press-fit biphasic (collagen and HA/βTCP) scaffold with cell-based therapy on cartilage and subchondral bone repair knee defect in rabbits. International orthopaedics, 42(7), 1755-1767. doi:10.1007/s00264-018-3999-3
  11. 10. Gangji, V., Soyfoo, M. S., Heuschling, A., Afzali, V., Moreno Reyes, M. R., Rasschaert, J., Gillet, C., Fils, J. F., & Hauzeur, J.-P. (2018). Non traumatic osteonecrosis of the femoral head is associated with low bone mass. Bone, 107, 88-92. doi:10.1016/j.bone.2017.11.005
  12. 11. Gillet, C., Dalla Valle, A., Gaspard, N., Spruyt, D., Vertongen, P., Lechanteur, J., Rigutto, S., Dragan, E.-R., Heuschling, A., Gangji, V., & Rasschaert, J. (2017). Osteonecrosis of the Femoral Head: Lipotoxicity Exacerbation in MSC and Modifications of the Bone Marrow Fluid. Endocrinology, 158(3), 490-502. doi:10.1210/en.2016-1687
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Suivant >>